Petros Pharmaceuticals (PTPI) Competitors $0.03 +0.00 (+0.67%) As of 01:03 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PTPI vs. JAGX, REVB, VRAX, EVAX, TTNP, QLGN, NBY, CNSP, GRI, and LIPOShould you be buying Petros Pharmaceuticals stock or one of its competitors? The main competitors of Petros Pharmaceuticals include Jaguar Animal Health (JAGX), Revelation Biosciences (REVB), Virax Biolabs Group (VRAX), Evaxion A/S (EVAX), Titan Pharmaceuticals (TTNP), Qualigen Therapeutics (QLGN), NovaBay Pharmaceuticals (NBY), CNS Pharmaceuticals (CNSP), GRI Bio (GRI), and Lipella Pharmaceuticals (LIPO). These companies are all part of the "pharmaceutical products" industry. Petros Pharmaceuticals vs. Its Competitors Jaguar Animal Health Revelation Biosciences Virax Biolabs Group Evaxion A/S Titan Pharmaceuticals Qualigen Therapeutics NovaBay Pharmaceuticals CNS Pharmaceuticals GRI Bio Lipella Pharmaceuticals Jaguar Animal Health (NASDAQ:JAGX) and Petros Pharmaceuticals (NASDAQ:PTPI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment. Which has more risk & volatility, JAGX or PTPI? Jaguar Animal Health has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Petros Pharmaceuticals has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Which has preferable earnings & valuation, JAGX or PTPI? Petros Pharmaceuticals has lower revenue, but higher earnings than Jaguar Animal Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJaguar Animal Health$11.69M0.34-$38.49MN/AN/APetros Pharmaceuticals$5.11M0.18-$8.16M-$60.870.00 Do analysts rate JAGX or PTPI? Jaguar Animal Health presently has a consensus target price of $60.00, suggesting a potential upside of 2,770.81%. Given Jaguar Animal Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Jaguar Animal Health is more favorable than Petros Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Petros Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer JAGX or PTPI? In the previous week, Petros Pharmaceuticals' average media sentiment score of 0.00 beat Jaguar Animal Health's score of -1.00 indicating that Petros Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Jaguar Animal Health Negative Petros Pharmaceuticals Neutral Do insiders and institutionals hold more shares of JAGX or PTPI? 12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 12.3% of Petros Pharmaceuticals shares are held by institutional investors. 4.6% of Jaguar Animal Health shares are held by company insiders. Comparatively, 12.3% of Petros Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is JAGX or PTPI more profitable? Petros Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -343.92%. Petros Pharmaceuticals' return on equity of -78.22% beat Jaguar Animal Health's return on equity.Company Net Margins Return on Equity Return on Assets Jaguar Animal Health-343.92% -432.91% -71.25% Petros Pharmaceuticals N/A -78.22%-23.50% SummaryPetros Pharmaceuticals beats Jaguar Animal Health on 8 of the 13 factors compared between the two stocks. Get Petros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PTPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTPI vs. The Competition Export to ExcelMetricPetros PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$932K$794.16M$5.46B$9.66BDividend YieldN/A4.84%3.99%4.14%P/E Ratio-0.011.3230.0324.98Price / Sales0.1825.15375.7076.70Price / CashN/A19.5635.9458.58Price / Book0.016.558.155.67Net Income-$8.16M-$4.07M$3.25B$265.39M7 Day PerformanceN/A-0.57%1.13%2.51%1 Month PerformanceN/A2.94%2.83%1.85%1 Year PerformanceN/A24.52%28.39%24.09% Petros Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTPIPetros PharmaceuticalsN/A$0.03+0.7%N/A-99.7%$932K$5.11M-0.0120JAGXJaguar Animal Health1.8299 of 5 stars$2.15+8.6%$60.00+2,690.7%-92.1%$3.79M$11.69M0.0050Negative NewsUpcoming EarningsShort Interest ↑REVBRevelation Biosciences0.3935 of 5 stars$2.54+4.1%N/A-95.0%$3.74MN/A-0.0110News CoverageVRAXVirax Biolabs Group3.1593 of 5 stars$0.84-0.6%$3.00+257.1%-27.6%$3.67M$6.33K0.005Gap UpEVAXEvaxion A/S1.6745 of 5 stars$2.72+4.2%$10.00+267.6%-76.6%$3.66M$3.34M-2.3460Upcoming EarningsTTNPTitan Pharmaceuticals0.2528 of 5 stars$3.99flatN/A-32.1%$3.65MN/A-0.8710Upcoming EarningsQLGNQualigen TherapeuticsN/A$2.07-4.6%N/A-82.3%$3.55M$4.98M0.0050NBYNovaBay Pharmaceuticals1.4677 of 5 stars$0.61+2.8%$0.85+39.3%+27.4%$3.55M$9.78M-0.0130CNSPCNS Pharmaceuticals2.0577 of 5 stars$7.51-2.5%$300.00+3,894.7%-93.8%$3.50MN/A0.005Upcoming EarningsGRIGRI Bio2.0089 of 5 stars$1.28-3.0%$22.00+1,618.8%-84.0%$3.30MN/A-0.111Upcoming EarningsShort Interest ↑LIPOLipella Pharmaceuticals1.3094 of 5 stars$0.67-5.5%N/A-86.8%$3.17M$536.36K-0.164Upcoming Earnings Related Companies and Tools Related Companies Jaguar Animal Health Competitors Revelation Biosciences Competitors Virax Biolabs Group Competitors Evaxion A/S Competitors Titan Pharmaceuticals Competitors Qualigen Therapeutics Competitors NovaBay Pharmaceuticals Competitors CNS Pharmaceuticals Competitors GRI Bio Competitors Lipella Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTPI) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
